Page last updated: 2024-09-04

ci 949 and thromboxane b2

ci 949 has been researched along with thromboxane b2 in 1 studies

Compound Research Comparison

Studies (ci 949)	Trials (ci 949)	Recent Studies (post-2010) (ci 949)	Studies (thromboxane b2)	Trials (thromboxane b2)	Recent Studies (post-2010) (thromboxane b2)
9	0	0	7,483	715	485

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Adolphson, RL; Chestnut, JC; Conroy, MC; Kennedy, JA; Thueson, DO; Wright, CD	1

Other Studies

1 other study(ies) available for ci 949 and thromboxane b2

Article	Year
Inhibition of histamine, leukotriene C4/D4, and thromboxane B2 release from human leukocytes and human chopped lung mast cells by the allergic mediator release inhibitor, CI-949. The Journal of allergy and clinical immunology, 1990, Volume: 86, Issue:6 Pt 1 Topics: Basophils; Calcimycin; Dose-Response Relationship, Drug; Histamine Antagonists; Histamine Release; Humans; Immunoglobulin E; Indoles; Lung; Mast Cells; SRS-A; Tetradecanoylphorbol Acetate; Tetrazoles; Thromboxane B2	1990

Article

Year

Inhibition of histamine, leukotriene C4/D4, and thromboxane B2 release from human leukocytes and human chopped lung mast cells by the allergic mediator release inhibitor, CI-949.

The Journal of allergy and clinical immunology, 1990, Volume: 86, Issue:6 Pt 1

Topics: Basophils; Calcimycin; Dose-Response Relationship, Drug; Histamine Antagonists; Histamine Release; Humans; Immunoglobulin E; Indoles; Lung; Mast Cells; SRS-A; Tetradecanoylphorbol Acetate; Tetrazoles; Thromboxane B2

1990